For special situations like vacations or event-filled weekends, receiving treatment multiple times in a week is generally safe for most healthy individuals
However, the existing literature on the effectiveness of the KD in several neurological disorders shows that it reduces symptoms and improves quality of life in several diseases when tested in small pilot studies, such as MS and Alzheimer's disease, but results from larger randomized clinical trials have not yet been reported
has a patent on EPO variants and is a member of the SINAPPS2 TSC
We have developed trans-cranial vascular doppler blood-brain barrier ultrasound imaging analysis, personalized IV infusions, therapeutic nerve blocks, cervicogenic headache treatments, spine interventions, nutrition strategies, peptide therapies, specialized lab analysis, stem cell therapies, regenerative interventions, prolotherapy, hydrodissection of nerve entrapments, hormone optimization for the syndrome of cognitive impairment, cognitive decline, brain fog, headaches and/or neck pain, plus there are also additional therapies under investigation like certain peptides (possibly including BPC-157, Semax, TB-500, Epithalon, P021, NVG-291, BIIB080, or others) and Sirtuin modulators listed above, as well as shockwave therapy, myofascial release, and image-guided nerve releases and interventional procedures that can relieve pain, release spasms, and increase lymphatic flow and treatment of underlying neuropathologies
